Kothe K, Aurich R, Kempf B
Klinik für Innere Medizin Theodor Brugsch, Humboldt-Universität zu Berlin.
Z Gesamte Inn Med. 1989 Nov 1;44(21):649-52.
The individual valuation of risks in patients with acute myocardial infarction on the basis of a monitoring of the creatine kinase (CK) is made evident as relevant to practice for the basic medical care. Thereby a classification of risk groups on the basis of CKmax (less than or equal to 23; greater than 23 less than or equal to 40; greater than 40 less than or equal to 60; greater than 60 mumol/l.s) is controlled. The measurement of the ejection fraction global was performed also according to risk groups (greater than 60; greater than 45 less than or equal to 60; greater than 30 less than or equal to 45; less than or equal to 30%). Parallel to this a classification of the patients according to the electrocardiogram (non-Q-wave, Q-wave) was retrospectively performed. The anamnestic information Re-AMI was individually taken into consideration for the evaluation of CKmax. In 2.5% of the patients in comparison to the ejection fraction the risk group classification of CKmax was globally carried out into a higher group without an an principal incorrect evaluation of the risk (slight, middle, high) in the first AMI. No patient with middle or high risk in the first AMI was incorrectly grouped according to the risk group CKmax or ejection fraction global.
基于肌酸激酶（CK）监测对急性心肌梗死患者的个体风险评估，在基础医疗护理实践中显示出其相关性。由此，根据CKmax（小于或等于23；大于23小于或等于40；大于40小于或等于60；大于60μmol/l·s）对风险组进行分类得以控制。还根据风险组（大于60；大于45小于或等于60；大于30小于或等于45；小于或等于30%）进行了整体射血分数的测量。与此同时，根据心电图（非Q波、Q波）对患者进行了回顾性分类。在评估CKmax时，对再发急性心肌梗死的既往信息进行了单独考量。与射血分数相比，2.5%的患者中，CKmax的风险组分类整体被归入更高组，且在首次急性心肌梗死中对风险（低、中、高）没有主要的错误评估。首次急性心肌梗死中处于中或高风险的患者，根据CKmax风险组或整体射血分数均未被错误分组。
